ProShare Advisors
ALXN

ProShare Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-290,153
Closed -$53.3M 2390
2021
Q2
$53.3M Sell
290,153
-1,377
-0.5% -$253K 0.16% 134
2021
Q1
$44.6M Buy
291,530
+33,516
+13% +$5.12M 0.14% 153
2020
Q4
$40.3M Buy
258,014
+29,300
+13% +$4.58M 0.15% 147
2020
Q3
$26.2M Buy
228,714
+27,370
+14% +$3.13M 0.12% 151
2020
Q2
$22.6M Buy
201,344
+15,655
+8% +$1.76M 0.12% 140
2020
Q1
$16.7M Sell
185,689
-59,965
-24% -$5.38M 0.12% 142
2019
Q4
$26.6M Buy
245,654
+18,488
+8% +$2M 0.12% 140
2019
Q3
$22.2M Buy
227,166
+7,041
+3% +$690K 0.12% 137
2019
Q2
$28.8M Sell
220,125
-26,755
-11% -$3.5M 0.17% 113
2019
Q1
$33.4M Buy
246,880
+1,517
+0.6% +$205K 0.2% 111
2018
Q4
$23.9M Buy
245,363
+24,774
+11% +$2.41M 0.17% 121
2018
Q3
$30.7M Sell
220,589
-24,111
-10% -$3.35M 0.21% 107
2018
Q2
$30.4M Sell
244,700
-23,668
-9% -$2.94M 0.2% 114
2018
Q1
$29.9M Buy
268,368
+7,435
+3% +$829K 0.19% 117
2017
Q4
$31.2M Buy
260,933
+52,727
+25% +$6.31M 0.22% 103
2017
Q3
$29.2M Buy
208,206
+3,041
+1% +$427K 0.27% 94
2017
Q2
$25M Buy
205,165
+30,098
+17% +$3.66M 0.25% 91
2017
Q1
$21.2M Sell
175,067
-20,715
-11% -$2.51M 0.22% 98
2016
Q4
$24M Buy
195,782
+24,065
+14% +$2.94M 0.27% 87
2016
Q3
$21M Sell
171,717
-27,762
-14% -$3.4M 0.29% 82
2016
Q2
$23.3M Buy
199,479
+4,537
+2% +$530K 0.3% 92
2016
Q1
$27.1M Sell
194,942
-45,831
-19% -$6.38M 0.37% 84
2015
Q4
$45.9M Buy
240,773
+13,602
+6% +$2.59M 0.56% 32
2015
Q3
$35.5M Sell
227,171
-8,206
-3% -$1.28M 0.5% 40
2015
Q2
$42.5M Sell
235,377
-4,385
-2% -$793K 0.59% 28
2015
Q1
$41.6M Buy
239,762
+44,363
+23% +$7.69M 0.49% 35
2014
Q4
$36.2M Buy
195,399
+50,040
+34% +$9.26M 0.42% 41
2014
Q3
$24.1M Sell
145,359
-45,716
-24% -$7.58M 0.32% 50
2014
Q2
$29.9M Sell
191,075
-39,713
-17% -$6.21M 0.39% 40
2014
Q1
$35.1M Buy
230,788
+93,789
+68% +$14.3M 0.44% 33
2013
Q4
$18.2M Buy
136,999
+45,794
+50% +$6.09M 0.27% 65
2013
Q3
$10.6M Sell
91,205
-3,167
-3% -$368K 0.25% 72
2013
Q2
$8.71M Buy
+94,372
New +$8.71M 0.17% 103